Predictions
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€2.28
11.03.20
11.03.20
-
12.03.20
12.03.20
22.81%
12.03.20
12.03.20
Quoin Pharmaceuticals Ltd. ADR
Start price
Target price
Perf. (%)
€78.50
11.03.20
11.03.20
-
16.03.20
16.03.20
-28.66%
16.03.20
16.03.20
Canopy Growth Corp
Start price
Target price
Perf. (%)
€12.40
11.03.20
11.03.20
€18.00
04.11.21
04.11.21
-7.21%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Therapix Biosciences Ltd ADR
Start price
Target price
Perf. (%)
€26.74
11.03.20
11.03.20
€70.00
20.07.20
20.07.20
-36.13%
20.07.20
20.07.20
Theravance Biopharma
Start price
Target price
Perf. (%)
€22.20
11.03.20
11.03.20
€25.00
21.08.20
21.08.20
-29.73%
21.08.20
21.08.20
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€64.45
11.03.20
11.03.20
€55.00
11.03.20
11.03.20
0.51%
11.03.20
11.03.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€352.50
10.03.20
10.03.20
€415.00
11.03.20
11.03.20
0.71%
11.03.20
11.03.20
Johnson & Johnson
Start price
Target price
Perf. (%)
€121.12
10.03.20
10.03.20
€130.00
20.03.20
20.03.20
-4.23%
20.03.20
20.03.20
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€413.60
10.03.20
10.03.20
-
16.03.20
16.03.20
-4.06%
16.03.20
16.03.20
Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€3.26
10.03.20
10.03.20
€4.50
10.03.20
10.03.20
-17.73%
10.03.20
10.03.20
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€352.50
10.03.20
10.03.20
€400.00
02.04.20
02.04.20
17.02%
02.04.20
02.04.20
Organovo Holdings Inc.
Start price
Target price
Perf. (%)
€5.00
09.03.20
09.03.20
-
18.03.20
18.03.20
-17.71%
18.03.20
18.03.20
Cocrystal Pharma Inc.
Start price
Target price
Perf. (%)
€15.27
09.03.20
09.03.20
-
06.04.20
06.04.20
-46.57%
06.04.20
06.04.20
Could be worthwhile Investment >10% per year
Good culture
Little innovation